Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEvery Mounjaro pen contains four doses, each administered once a week, giving you a full four-week supply in a single pen. That applies to all six UK strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. One pen, four injections, one month of treatment. Mounjaro is a prescription-only medicine, so your next pen requires a clinical review before it can be dispensed — but more on that below.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Pull a Mounjaro pen out of the fridge (the inner door shelf works well) convenient without the temperature swings of the main shelf) and you are holding exactly four doses. The pen is pre-filled and pre-set to the strength printed on the label; there is no dial to adjust and no way to split or combine doses. Each press of the button delivers one full weekly injection.
Because each dose is delivered once a week, a single pen covers weeks one through four of that particular strength. If you want a fuller breakdown of that count, our page on how many doses of Mounjaro you get per pen explains the structure clearly. At that point you need a new pen, and if your strength is changing, a new prescription to match.
The full Mounjaro overview covers how the medicine works as a dual GIP and GLP-1 receptor agonist, but for counting purposes the structure is straightforward: one pen, four weekly injections, one calendar month. That pattern holds across every strength in the UK range.
Most people start on 2.5 mg. That first pen is a tolerability stage, your body is adjusting to the medicine rather than experiencing its full weight-management effect. After four weeks, a prescriber typically reviews progress and may move you to 5 mg, then upward in roughly four-week steps toward the highest strength you tolerate well.
Each strength change means a new pen at the new dose. So if you have questions about what to expect from a specific strength (say, how the 5 mg pen compares to starter doses in terms of side effects and early results) that is worth raising with your prescriber before the transition, not after.
The titration schedule is guided by your prescriber based on your response and tolerability. Timing, pace and whether to hold at a particular strength are clinical decisions; the Patient Information Leaflet and your prescriber are the right sources for personal guidance on when to move up.
For a deeper look at dose-specific questions, our page on how many doses are in the 7.5 mg pen covers that transition point in detail.
The fourth injection empties the pen. That moment is also a natural checkpoint in your treatment. Because Mounjaro is a prescription-only medicine, your next supply requires a fresh clinical assessment, a real prescriber looks at how the current strength is sitting with you, whether a dose increase is appropriate, and whether treatment should continue.
At nume, that review happens before every repeat order, without exception. A GPhC-registered Independent Prescriber reads your answers the same day, not software, not an automated system. If you are transferring from another provider or moving to a higher strength, evidence of your current treatment is checked as part of that process.
If you are curious about what private treatment costs across the dose range, the Mounjaro pricing page sets out the context clearly. And if you want to understand the side-effect profile as doses increase, the 10 mg side-effects page is a good reference before that conversation with your prescriber.
According to the NHS tirzepatide medicine guide, treatment should be reviewed regularly and continued only where it remains clinically appropriate. NICE's appraisal of tirzepatide (TA1026) reinforces that a prescriber should assess progress before each stage of treatment continues. That is the framework our clinical team works within.
Between injections, the pen lives in the fridge at 2–8 °C. It should not be frozen, and should not be left sitting on a sunny windowsill or in a hot car. For the precise room-temperature window (the time you can keep the pen out if refrigeration is temporarily unavailable) the Patient Information Leaflet inside the box is the definitive source; we do not quote that figure here because it carries conditions that matter.
Rotate your injection site each week: abdomen, thigh and upper arm are all suitable, but using the same spot four times in a row can cause skin reactions. By the time you reach the fourth dose on week four, the pen will lock automatically after use. Dispose of it in a sharps container, household bins are not appropriate for used injection devices.
Practical questions about managing your pen across a month (travel, missed doses, what to do if a dose is delayed) are best addressed with your prescriber or by reading the leaflet. Our FAQs page also covers common queries that come up between repeat orders.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.